A detailed history of Bip Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bip Wealth, LLC holds 945 shares of LLY stock, worth $881,212. This represents 0.05% of its overall portfolio holdings.

Number of Shares
945
Previous 896 5.47%
Holding current value
$881,212
Previous $522 Million 40.76%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $29,017 - $38,821
49 Added 5.47%
945 $735 Million
Q4 2023

Feb 02, 2024

BUY
$525.19 - $619.13 $147,053 - $173,356
280 Added 45.45%
896 $522 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $38,688 - $53,337
-89 Reduced 12.62%
616 $331 Million
Q2 2023

Jul 27, 2023

SELL
$350.74 - $468.98 $7,014 - $9,379
-20 Reduced 2.76%
705 $331 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $225,206 - $264,494
725 New
725 $249 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $886B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bip Wealth, LLC Portfolio

Follow Bip Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bip Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bip Wealth, LLC with notifications on news.